On Thursday, June 22, 2017, the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, a subcommittee of the Senate Committee on Appropriations, held a hearing to review the FY2018 budget request for the NIH. Click here to read Dr. Collins' testimony.
The Global Health Program Advisory Service (GHPAS) is designed to connect people who, because of their substantial programmatic experience in global health, could provide requested guidance that will help an institution create, grow, and strengthen their global health programs.
The GHPAS provides mentorship to a CUGH member global health program (mentee). Preference is given to programs that are in their early or middle stages of development.
On Tuesday, June 20, 2017, Vice President of CSIS, Steve Morrison, and Senior Director of Policy and Research at ASPPH, Tony Mazzaschi, discussed what you can do to fight President Trump's proposed budget cuts to U.S. global health programs. CUGH Executive Director, Keith Martin, moderated the discussion.
Click here to watch the recording.
Click here to download the slides.
The Smart Pod is a low cost, innovative, and rapidly deployable clinical solution. It is a clinical facility that is setup in under 5 minutes with 4 people and can quickly scale up for emergencies (infectious disease outbreaks or natural disasters) when there is no healthcare facility, or to augment already existing facilities. The Pod is optimized for infection control. It's tablet-based education and training apps and robust patient tracking and communication systems within the unit improve patient care and protect providers working in the unit.
Postpartum hemorrhage (PPH) is the largest cause of maternal mortality globally. The majority of these deaths occur in low resource settings, where infrastructure and health staff are limited, rendering it imperative to consider PPH treatment options that do not require administration by a skilled provider or a cold chain. One such option is misoprostol, a prostaglandin E1 analog, that has shown to be effective in treating PPH. However, there is little data on the use of misoprostol for this indication at the community level, where it is likely to be most beneficial.